Fervent Pharmaceuticals To Attend BIO 2017 In San Diego
Fervent Pharmaceuticals CEO George Royster will be attending this year’s BIO International Convention, which is being held in San Diego, California, from June 19-22. Mr. Royster will be on hand, along with other Fervent Pharmaceuticals representatives, to meet with industry leaders to discuss business opportunities associated with FP-101, Fervent Pharmaceuticals’ treatment for symptoms associated with menopause, which is currently in Phase II development.
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and around the world. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
To meet with a Fervent Pharmaceuticals representative in advance of the BIO Convention, or to learn more about how we’re making a positive impact on women’s health, get in touch using our contact form or email us at email@example.com